Literature DB >> 33659493

Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK Cells.

Janine E Melsen1, Maria Themeli2, Monique M van Ostaijen-Ten Dam1, Els van Beelen3, Gertjan Lugthart1, Rob C Hoeben4, Marco W Schilham1, Harald M Mikkers4.   

Abstract

Natural killer (NK) cells are innate immune cells, characterized by their cytotoxic capacity, and chemokine and cytokine secretion upon activation. Human NK cells are identified by CD56 expression. Circulating NK cells can be further subdivided into the CD56bright (~10%) and CD56dim NK cell subsets (~90%). NK cell-like cells can also be derived from human induced pluripotent stem cells (iPSC). To study the chemokine and cytokine secretion profile of the distinct heterogenous NK cell subsets, intracellular flow cytometry staining can be performed. However, this assay is challenging when the starting material is limited. Alternatively, NK cell subsets can be enriched, sorted, stimulated, and functionally profiled by measuring secreted effector molecules in the supernatant by Luminex. Here, we provide a rapid and straightforward protocol for the isolation and stimulation of primary NK cells or iPSC-derived NK cell-like cells, and subsequent detection of secreted cytokines and chemokines, which is also applicable for a low number of cells.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  CD56; Chemokines; Cytokines; Induced pluripotent stem cells; Luminex; Natural killer cells; Peripheral blood

Year:  2020        PMID: 33659493      PMCID: PMC7842530          DOI: 10.21769/BioProtoc.3845

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Comprehensive assessment of chemokine expression profiles by flow cytometry.

Authors:  Jens Eberlein; Tom T Nguyen; Francisco Victorino; Lucy Golden-Mason; Hugo R Rosen; Dirk Homann
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

2.  Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.

Authors:  Maria Themeli; Christopher C Kloss; Giovanni Ciriello; Victor D Fedorov; Fabiana Perna; Mithat Gonen; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2013-08-11       Impact factor: 54.908

3.  Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.

Authors:  Gertjan Lugthart; Janine E Melsen; Carly Vervat; Monique M van Ostaijen-Ten Dam; Willem E Corver; Dave L Roelen; Jeroen van Bergen; Maarten J D van Tol; Arjan C Lankester; Marco W Schilham
Journal:  J Immunol       Date:  2016-05-25       Impact factor: 5.422

4.  Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.

Authors:  David A Knorr; Zhenya Ni; David Hermanson; Melinda K Hexum; Laura Bendzick; Laurence J N Cooper; Dean A Lee; Dan S Kaufman
Journal:  Stem Cells Transl Med       Date:  2013-03-20       Impact factor: 6.940

5.  Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.

Authors:  Jieming Zeng; Shin Yi Tang; Lai Ling Toh; Shu Wang
Journal:  Stem Cell Reports       Date:  2017-11-22       Impact factor: 7.765

Review 6.  Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.

Authors:  Janine E Melsen; Gertjan Lugthart; Arjan C Lankester; Marco W Schilham
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561

7.  iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests.

Authors:  Maria Themeli; Amiet Chhatta; Hester Boersma; Henk Jan Prins; Martijn Cordes; Edwin de Wilt; Aïda Shahrabi Farahani; Bart Vandekerckhove; Mirjam van der Burg; Rob C Hoeben; Frank J T Staal; Harald M M Mikkers
Journal:  Stem Cell Reports       Date:  2020-01-16       Impact factor: 7.765

  7 in total
  2 in total

Review 1.  CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.

Authors:  Ezgi Elmas; Noushin Saljoughian; Marcelo de Souza Fernandes Pereira; Brian P Tullius; Kinnari Sorathia; Robin J Nakkula; Dean A Lee; Meisam Naeimi Kararoudi
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

2.  CITEMOXMBD: A flexible single-cell multimodal omics analysis framework to reveal the heterogeneity of immune cells.

Authors:  Huan Hu; Ruiqi Liu; Chunlin Zhao; Yuer Lu; Yichun Xiong; Lingling Chen; Jun Jin; Yunlong Ma; Jianzhong Su; Zhengquan Yu; Feng Cheng; Fangfu Ye; Liyu Liu; Qi Zhao; Jianwei Shuai
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.